Intesta Pylostat after Helicobacter Pylori eradication therapy 14 sachets
Description:
lntesta Pylostat is a food for special medical purposes in sachet form for dietary management during and after Helicobacter Pylori eradication therapy. This therapy involves the use of antibiotics and medications that reduce gastric acid secretion to eliminate the H. pylori bacteria, responsible for stomach diseases such as ulcers and chronic gastric mucositis. The synergy of lntesta Pylostat® ingredients promotes better treatment tolerance, supports digestive system regeneration, and helps to quickly regain digestive comfort after therapy.
Recommended Daily Portion
: Adults: The recommended dose is 1 sachet daily, preferably with a main meal, during and after antibiotic therapy. Your doctor may recommend a different duration and dosage. lntesta Pylostat should be taken directly from the sachet (do not chew it!) and washed down with water or mixed with a thick food, such as yogurt. The product ingredients are insoluble in water or other beverages, so do not mix them with liquids.
Ingredients
Mixture of fully hydrogenated triglycerides of fatty acids from palm oil, sodium butyrate, live yeast Saccharomyces boulardii CNCM I-3799, inactivated Lactobacillus reuteri 17648 strain, natural cranberry flavor, sweetener: acesulfame K.
100 g of product contains: energy value 2482 kJ/ 594 kcal, fat 53 g, including fatty acids 52 g; carbohydrates 17 g, including sugars 3 g; protein 8.4 g, salt 12.1 g, including sodium 4.8 g, microencapsulated sodium butyrate 73.5 g, including sodium butyrate 22 g, Saccharomyces boulardii CNCM 1-3799 178.4 g, Lactobacillus reuteri DSM 17648 (inactivated) 7.3 g.
1 sachet contains: energy value 68 kJ/ 16 kcal, fat 1.4 g, including fatty acids 1.4 g; carbohydrates < 0.5 g, including sugars < 0.5 g; protein < 0.5 g; salt 0.33 g, including sodium 0.13 g, microencapsulated sodium butyrate 2 g, including sodium butyrate 0.6 g, Saccharomyces boulardii CNCM 1-3799 0.5 g (5 x 10^9 CFU*), Lactobacillus reuteri DSM 17648 (inactivated) 0.2 g.
Safety warnings
Contraindications - Hypersensitivity to any of the product ingredients. Use under medical supervision. The product is not intended for parenteral use. It cannot be used as the sole source of nutrition. Contains a source of phenylalanine. There are no data on the use of the product by pregnant and breastfeeding women. Store at up to 25°C. Protect from light and moisture. Product for special medical purposes Intesta Max contains a sweetener (acesulfame K). Manufacturer
Net content
38.1 g (2.72 g x 14 sachets)
Manufacturer / Marketing Authorisation Holder
Biolek Sp. z o. o. Bioton
Macierzysz Group, ul. Poznańska 12
05-850 Ożarów Mazowiecki